Independent

[flipper44]

NWBO agreement to acquire Advent. One (of many) possible implication(s).

Something more to think about. NWBO obviously partly justified the separation between Advent and NWBO because DCVax-l was paid for by private means (when people could obtain the funds) allowed by the UK compassionate care access program.

NWBO was not allowed to profit, and Advent was only allowed to use compassionate funds for costs which included keeping doors open.

It stands to reason, although not certain, that NWBO’s willingness to acquire Advent is another sign commercial reimbursement is on the horizon.

No longer, perhaps, is there going to be a compulsion to firewall the manufacturer from the for profit company when it comes to treating GBM with DCVax-l.

We have not been updated on what possible interim funding pathways NWBO might be working on, or whether they’ve made major strides with a forthcoming evidence submission to NICE, but NWBO’s PR language recently evolved to contemplate a future MAA approval without qualification in the same PR it recently announced its agreement to acquire Advent.